We Think That There Are More Issues For Sino BiologicalInc (SZSE:301047) Than Just Sluggish Earnings

Simply Wall StNov 4 17:50 ET

Yiqiao Shenzhou (301047.SZ): The second phase has repurchased 3.59% of the shares accumulated.

Gelonghui on November 4th | Yiqiao Shenzhou (301047.SZ) announced that as of October 31, 2024, the company used its own funds to repurchase shares through a special securities account for centralized bidding trading. The total number of shares repurchased is 4,533,890 shares, accounting for 3.59% of the company's total share capital. The highest fill price is RMB 58.70 per share, and the lowest fill price is RMB 53.55 per share, with a total transaction amount of RMB 253.3026 million yuan (excluding trading fees). The above repurchase implementation meets the company's established repurchase plan and relevant laws and regulations.

Gelonghui FinanceNov 4 03:54 ET

Is Sino Biological,Inc.'s (SZSE:301047) Recent Performance Underpinned By Weak Financials?

Simply Wall StNov 1 21:10 ET

Yiqiao Shenzhou: Report for the third quarter of 2024

SZSIOct 22 12:00 ET · Announcements

Unconventional business continues to drag down Yiqiao Shenzhou's performance. The cumulative stock buyback has exceeded 0.4 billion yuan | Interpretations

①Affected by factors such as the decline in unconventional business income and fluctuations in cash management income, Yiqiao Shenzhou's third quarter revenue and net income attributable to the parent both declined; ②Increased investment in CRO services and conventional reagent business caused the company's cost of goods sold to increase by more than 30% year-on-year; ③Yiqiao Shenzhou has repurchased the company's shares twice this year, totaling more than 0.4 billion yuan.

cls.cnOct 22 08:28 ET

Yiqiao Shenzhou (301047.SZ): The net income in the third quarter was 28.3747 million yuan, a year-on-year decrease of 59.20%.

On October 22, Yiqiao Shenzhou (301047.SZ) released its financial report for the third quarter of 2024, with revenue of 0.159 billion yuan, a 13.28% year-on-year decrease; net income attributable to shareholders of the listed company was 28.3747 million yuan, a 59.20% year-on-year decrease; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 10.3907 million yuan, a 81.27% year-on-year decrease; and the basic earnings per share was 0.2213 yuan.

Gelonghui FinanceOct 22 05:07 ET